DNA-HPV TRANSITION RATE OF WOMANIN CAN THO CITY FROM 2013 TO 2020
Main Article Content
Abstract
Background: HPV is identified as the cause of 99% of cervical cancers. 70% of women infected with HPV will be cured after 1 year, 90% will be cured after 2 years and most cases will heal spontaneously, about 5 - 10% of women with persistent HPV infection will develop to pre- cervical cancer. Objectives: The study was designed to determine the ratio of HPV infection, HPV type and DNA-HPV transition rates of women in Can Tho City from 2013 to 2020. Materials and methods: Both a retrospective - prospective cohort study was employed to complete the study. Interviews, gynecological examinations and HPV testing were used to collect data from 213 women in 2018 and 2020. We identified the rate of HPV positive and HPV type in 2018 and 2020. The results were compared with the past result in 2013 to evaluate the development of HPV infection over time: conversion to HPV positive state, clearance of HPV state and remaining HPV negative or positive state. Results: Rate of HPV infection was 23% (2018) of which HPV type 52 was 21.2%; type 16 was 19.2%. In 2020, the rate was 20.2%, of which type 52 and 16 were 19.1%, types 18 and 58 were 12.8%; the rate of change in the bad direction of HPV was 14.3%; in the good direction of HPV was 68.5%; remaining HPV negative or positive rate was 67.1%. Conclusion: The rate of HPV infection was changed over time and HPV types infection mainly were 52 and 16.
Article Details
Keywords
HPV infected, related factors, cervical cancer
References
2. Nguyễn Vũ Quốc Huy (2019), Bệnh lý cổ tử cung – sách chuyên khảo. Nhà xuất bản Đại học Huế, tr.1-72, 145-154.
3. Trương Quang Vinh (2010), Nghiên cứu nhiễm Human papilloma virus ở các phụ nữ có các tổn thương tiền ung thư và ung thư cổ tử cung. Luận án tiến sĩ Y học, Trường Đại học Y Dược Huế.
4. Abba Kabir et al. (2019), Prevalence of human papillomavirus genotypes in cervical cancer in Maiduguri, Nigeria. The Pan African Medical Journal, 33: 284.
5. Ala Eddin Al Moustafa, Rana Al-Awadhi, Nabiha Missaoui et al. (2014), Human papillomaviruses-related cancers Presence and prevention strategies in the Middle East and North African Regions. Human Vaccines & Immunotherapeutics, 10 (7), pp.1812-1821.
6. A. Bardina, S. Vaccarellab, G.M. Cliffordb et al. (2008), Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. European journal of cancer, 44, pp.557-564.
7. Bigras G. and F. de Marval (2005), The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women. British Journal of Cancer, 93, pp.575-581.
8. Bruni L, Albero G, Serrano B et al. (2019), Human Papillomavirus and Related Diseases Report, Viet Nam. ICO/IARC Information Centre on HPV and Cancer, HPV Information Centre.
9. Chichao Xia, Sile Li, Teng Long et al. (2021), Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asi. Cancers, 13 (11), pp.1-33.
10. Chyong-Huey Lai, Angel Chao, Chee-Jen Chang et al. (2008), Host and viral factors in relation to clearance of human papillomavirus infection: A cohort study in Taiwan. International Journal of Cancer, Volume 123, Issue 7, pp.1685-1692.
11. Johnson Katanga, Susanne K. Kjaer, Rachel Manongi et al. (2019), Performance of care HPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study. Plos One, pp. 1 - 13.
12. Mallory E. Harden, Karl Munger (2017), Human papillomavirus molecular biology, Mutation Research. Elsevier, 772, pp.3-12.
13. Nogara P.R.B., Manfroni L.A.R., Consolaro M. E. L. (2013), Frequency of cervical intraepithelial neoplasia grade II or worse in women with a persistent low - grade squamous intraepithelial lesion seen by papanicolaou smears. Arch Gynecol Obstetrics, 288(5), pp.1125-1130.
14. Rozendaal L, Walboomers JMM, van der Linden JC et al. (1996), PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal smears. Int J Cancer, 68, pp.766-769.
15. Santiago Melón, Marta Alvarez-Argüelles and María de Oña (2013), Molecular Diagnosis of Human Papillomavirus Infections. Human Papillomavirus and related diseases, Chapter 1, pp.1-26.